Clinical Trial Detail

NCT ID NCT04134312
Title A Phase 1 Open Label Trial of Intravenous Administration of MVA-BN-Brachyury Vaccine in Patients With Advanced Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bavarian Nordic
Indications

hepatocellular carcinoma

breast cancer

ovarian cancer

prostate cancer

colorectal cancer

chordoma

kidney cancer

lung non-small cell carcinoma

pancreatic cancer

lung small cell carcinoma

urinary bladder cancer

Therapies

MVA-BN-Brachyury

Age Groups: adult senior

No variant requirements are available.